Regen BioPharma Inc (RGBP) stock
RGBPOTCPharmaceutical PreparationsFiscal year ends September 30Also trades as RGBPP
$0.00+0.00 (+50.00%)
Close on Oct 19, 2026Market cap $92.33KP/E –Yield –
Earnings
Regen BioPharma's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
–
Not yet scheduled
Revenue
–
EPS
–
Latest guidance
None
No outlook given in releases
Quarterly results
Revenue and earnings per share from each of Regen BioPharma's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q4 FY2024ended Sep 30, 2024 | Nov 29, 2024before the open | – | – | – | Release |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
Regen BioPharma has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When Regen BioPharma puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases Regen BioPharma filed with the SEC as exhibits to Form 8-K or 6-K
See a number that looks wrong?